Chronic care management startup WellTherory has launched an enterprise solution aimed at employers and payers for autoimmune care. The platform tackles the hidden costs and productivity impacts of untreated autoimmune diseases.
The company’s enterprise solution is a virtual care platform that addresses the underlying causes of autoimmunity and provides whole-body care, including community-based programs. It integrates into an enterprise's existing ecosystem and offers tailored support for employers and payers.
Since its launch in November 2022 , WellTheory claims its direct-to-consumer solution has recorded an 85% reduction in fatigue, a 53% decrease in pain, and a 74% increase in overall life satisfaction within 20 weeks. Additionally, it has led to healthcare cost savings, with an 85% decrease in ER and urgent care visits within 16 weeks and estimated annual savings of over USD 11,000 per member on biologics.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.